The app for independent voices
The United States Food and Drug Administration's Center for Biologics Evaluation and Research has established a follow-up period of 5 to 15 years for novel genetic products to monitor for any long-term adverse effects that may emerge in the exposed population[18]. With the passage of time, we have learned much from the evaluation of many vaccine-injured victims who have symptoms months to years after injection[19-21]. Brogna et al[22] found vaccine-generated stabilized prefusion Spike protein in subjects up to 6 months after COVID-19 mRNA vaccination. Cardiac abnormalities have been observed for at least a year following the initial diagnosis of COVID-19 vaccine-induced myocarditis, suggesting the potential for long-term effects[23]. As of January 13, 2025, we are unaware of any published risk stratification approach for the prevention of COVID-19 vaccine-induced cardiac arrest. Thus, we propose a comprehensive strategy to address this concerning gap in knowledge.
The largest COVID-19 vaccine safety study to date with approximately 99 million vaccinated individuals found that the risk of myocarditis was significantly elevated after mRNA COVID-19 vaccinations, with the risk being 510% higher following the second dose of the mRNA-1273 vaccine and 186% higher following the second dose of the BNT162b2 vaccine, compared to baseline rates[15]. Hulscher et al[16] have demonstrated that cardiac arrest within a few weeks of COVID-19 vaccination is likely caused by vaccine myocarditis with no prior premonitory phase that allows for detection. Rose et al[17] found that among individuals with clinical myocarditis shortly after COVID-19 vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), the mortality rate was 2.9%.
Lue lisää
The U.S. Food and Drug Administration (FDA) has admitted that people who received Covid mRNA “vaccines” are at risk of suffering from a deadly blood clot for up to 15 years after they received their last injection.
The shocking admission was revealed in a new peer-reviewed study published in the prestigious International Journal of Innovative Research in Medical Science.
According to the study, the FDA’s Center for Biologics Evaluation and Research admits that the “regulatory window of concern” for a novel genetic product, such as Covid mRNA “vaccines,” is 5-15 years.
Worryingly, the admission suggests that the vaccinated population may be facing a wave of surging blood clots as the Covid shots were only rolled out for public use roughly four years ago.
The study suggested this means fatal pulmonary hemorrhage should be considered a potential “consequence of the novel product even months to years after the last injection.”
“The FDA itself is saying the period of concern for these blood clots is 5 to 15 years,” Holland said.